GGrantIndex
← Leaderboards

Seymour Packman

University Of California San Francisco

$961,450
Attributed
$961,450
Total exposure
6
Grants
1
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $185.5K · FY200507
$200K$150K$100K$50K$0
'05
'06
'07

Funding mix

By agency

NIH$961,450 · 6

By mechanism

T32$851,063 · 1
M01$110,387 · 5

Top collaborators

No co-investigators on record.

Most similar at University Of California San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Research

Research focus

Clinical ResearchHuman SubjectHuman Therapy EvaluationMetabolism Disorder ChemotherapyInborn Carbohydrate Metabolism DisorderInborn Aminoacid Metabolism DisorderFamily GeneticsMenkes'SyndromePathologic ProcessChild (0-11)Patient Oriented ResearchRecombinant ProteinsClinical TrialsEnzyme TherapyFabry'S DiseaseKidney FunctionAlpha GalactosidaseInborn Metabolism DisorderInborn Metabolism Disorder DiagnosisPost-Doctoral TrainingDrug Screening /EvaluationCreatinineCardiovascular FunctionBrain Disorders

Grant awards (22)

Postdoctoral Training in Medical Genetics$118,040
T32 · FY2007 · GM · contact PI
Postdoctoral Training in Medical Genetics$185,475
T32 · FY2006 · GM · contact PI
Postdoctoral Training in Medical Genetics$75,806
T32 · FY2005 · GM
MULTI-CENTER, OPEN LABEL OF FABRAZYME IN PATIENTS WITH FABRY DISEASE$28,989
M01 · FY2005 · RR
CLINICAL INVESTIGATION OF THE PATIENT WITH INBORN ERROR OF METABOLISM$16,147
M01 · FY2005 · RR
Postdoctoral Training in Medical Genetics$180,214
T32 · FY2004 · GM
Clinical investigation of the patient with inborn error of metabolism$15,471
M01 · FY2004 · RR
Multi-center, open label of Fabrazyme in patients with Fabry disease$5,950
M01 · FY2004 · RR
Safety and efficacy of recombinant human alpha-galactosidase A$574
M01 · FY2004 · RR
Postdoctoral Training in Medical Genetics$165,699
T32 · FY2003 · GM
NATURAL HISTORY OF SYMPTOMATIC MENKES SYNDROME HETEROZYGOSITY$0
M01 · FY2002 · RR
CLINICAL INVESTIGATION OF PATIENTS WITH INBORN ERRORS OF METABOLISM$0
M01 · FY2002 · RR
POSTDOCTORAL TRAINING IN MEDICAL GENETICS$43,622
T32 · FY2001 · GM
NATURAL HISTORY OF SYMPTOMATIC MENKES SYNDROME HETEROZYGOSITY$0
M01 · FY2001 · RR
CLINICAL INVESTIGATION OF PATIENTS WITH INBORN ERRORS OF METABOLISM$0
M01 · FY2001 · RR
POSTDOCTORAL TRAINING IN MEDICAL GENETICS$82,207
T32 · FY2000 · GM
CLINICAL INVESTIGATION OF PATIENTS WITH INBORN ERRORS OF METABOLISM$25,799
M01 · FY2000 · RR
NATURAL HISTORY OF SYMPTOMATIC MENKES SYNDROME HETEROZYGOSITY$17,457
M01 · FY2000 · RR
NATURAL HISTORY OF SYMPTOMATIC MENKES SYNDROME HETEROZYGOSITY$0
M01 · FY2000 · RR
NATURAL HISTORY OF SYMPTOMATIC MENKES SYNDROME HETEROZYGOSITY$0
M01 · FY2000 · RR
CLINICAL INVESTIGATION OF PATIENTS WITH INBORN ERRORS OF METABOLISM$0
M01 · FY2000 · RR
CLINICAL INVESTIGATION OF PATIENTS WITH INBORN ERRORS OF METABOLISM$0
M01 · FY2000 · RR